Analysis of MIR27A (rs11671784) Variant Association with Systemic Lupus Erythematous

Multiple microRNAs (miRs) are associated with systemic autoimmune disease susceptibility/phenotype, including systemic lupus erythematosus (SLE). With this work, we aimed to unravel the association of the miR-27a gene (MIR27A) rs11671784G/A variant with SLE risk/severity. One-hundred sixty-three adult patients with SLE and matched controls were included. A TaqMan allelic discrimination assay was applied for MIR27A genotyping. Logistic regression models were run to test the association with SLE susceptibility/risk. Genotyping of 326 participants revealed that the heterozygote form was the most common genotype among the study cohort, accounting for 72% of the population (n = 234), while A/A and G/G represented 15% (n = 49) and 13% (n = 43), respectively. Similarly, the most prevalent genotype among cases was the A/G genotype, which was present in approximately 93.3% of cases (n = 152). In contrast, only eight and three patients had A/A and G/G genotypes, respectively. The MIR27A rs11671784 variant conferred protection against the development of SLE in several genetic models, including heterozygous (G/A vs. A/A; OR = 0.10, 95% CI = 0.05–0.23), dominant (G/A + G/G vs. AA; OR = 0.15, 95% CI = 0.07–0.34), and overdominant (G/A vs. A/A + G/G; OR = 0.07, 95% CI = 0.04–0.14) models. However, the G/G genotype was associated with increased SLE risk in the recessive model (G/G vs. A/A+ G/G; OR = 17.34, 95% CI = 5.24–57.38). Furthermore, the variant showed significant associations with musculoskeletal and mucocutaneous manifestations in the patient cohort (p = 0.035 and 0.009, respectively) and platelet and white blood cell counts (p = 0.034 and 0.049, respectively). In conclusion, the MIR27A rs11671784 variant showed a potentially significant association with SLE susceptibility/risk in the studied population. Larger-scale studies on multiethnic populations are recommended to verify the results.

[1]  M. González-Gay,et al.  Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients , 2022, Biomolecules.

[2]  M. Guma,et al.  Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes , 2022, Frontiers in Immunology.

[3]  Huali Zhang,et al.  EZH2: Its regulation and roles in immune disturbance of SLE , 2022, Frontiers in Pharmacology.

[4]  J. D. Di Noia,et al.  AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination , 2022, Science advances.

[5]  A. Nongnuch,et al.  Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios , 2022, PloS one.

[6]  M. Fawzy,et al.  MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease , 2021, Experimental and therapeutic medicine.

[7]  M. Assarehzadegan,et al.  MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis , 2021, Scientific Reports.

[8]  M. Fawzy,et al.  Association of microRNA-34a rs2666433 (A/G) Variant with Systemic Lupus Erythematosus in Female Patients: A Case-Control Study , 2021, Journal of clinical medicine.

[9]  Peizeng Yang,et al.  Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease , 2021, Disease markers.

[10]  S. Mohammadi,et al.  Genetic variation in CYP1A1 and AHRR genes increase the risk of systemic lupus erythematosus and exacerbate disease severity in smoker patients , 2021, Journal of biochemical and molecular toxicology.

[11]  Y. Errami,et al.  MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis , 2021, Cancers.

[12]  Lifeng Chen,et al.  Upregulating miR-27a-3p inhibits cell proliferation and inflammation of rheumatoid arthritis synovial fibroblasts through targeting toll-like receptor 5 , 2021, Experimental and therapeutic medicine.

[13]  Ying Zhao,et al.  ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells , 2021, Frontiers in Immunology.

[14]  D. Ribatti,et al.  SMADS-Mediate Molecular Mechanisms in Sjögren’s Syndrome , 2021, International journal of molecular sciences.

[15]  Sangdun Choi,et al.  Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook , 2021, International journal of molecular sciences.

[16]  E. Andrés-León,et al.  The Implications of ncRNAs in the Development of Human Diseases , 2021, Non-coding RNA.

[17]  R. Zhao,et al.  Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus , 2021, Frontiers in Immunology.

[18]  Wei Wei,et al.  Immuno-Hippo: Research Progress of the Hippo Pathway in Autoimmune Disease. , 2020, Immunology letters.

[19]  Ziye Wang,et al.  IFN-γ Mediates the Development of Systemic Lupus Erythematosus , 2020, BioMed research international.

[20]  Afaf T. Ibrahiem,et al.  Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study , 2020, Scientific Reports.

[21]  M. Fawzy,et al.  Association of microRNA 17 host gene variant (rs4284505) with susceptibility and severity of systemic lupus erythematosus , 2020, Immunity, inflammation and disease.

[22]  Sudong Liu,et al.  Circulating Exosomal microRNAs as Biomarkers of Systemic Lupus Erythematosus , 2020, Clinics.

[23]  Q. Lu,et al.  The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review , 2020, Journal of Autoimmunity.

[24]  Jingyan Dong,et al.  Association of two polymorphisms of miRNA-146a rs2910164 (G > C) and miRNA-499 rs3746444 (T > C) with asthma: a meta-analysis , 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

[25]  G. C,et al.  Investigating the role of microRNA-27a gene polymorphisms and its interactive effect with risk factors in gastrointestinal cancers , 2020, Heliyon.

[26]  Qing Zhou,et al.  New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond , 2020, Journal of clinical medicine.

[27]  K. Kavousi,et al.  An integrative Bayesian network approach to highlight key drivers in systemic lupus erythematosus , 2020, Arthritis Research & Therapy.

[28]  C. E. Condrat,et al.  miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis , 2020, Cells.

[29]  Xiaoqiong Gu,et al.  Association between the miRNA‐149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population , 2019, Journal of clinical laboratory analysis.

[30]  M. Infantino,et al.  European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view , 2019, Annals of the Rheumatic Diseases.

[31]  A. T. R. de Vasconcelos,et al.  miRNA Genetic Variants Alter Their Secondary Structure and Expression in Patients With RASopathies Syndromes , 2019, Front. Genet..

[32]  D. Gladman,et al.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus , 2019, Arthritis & rheumatology.

[33]  Se Jin Park,et al.  Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis , 2019, Disease markers.

[34]  T. Aune,et al.  Juvenile idiopathic arthritis associated with a mutation in GATA3 , 2019, Arthritis Research & Therapy.

[35]  G. Novelli,et al.  The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A , 2019, International journal of molecular sciences.

[36]  S. Ooka,et al.  Anti-IL-10 antibody in systemic lupus erythematosus , 2019, Open access rheumatology : research and reviews.

[37]  M. Fawzy,et al.  Deregulated MicroRNA Signature Following Glioblastoma Irradiation , 2019, Cancer control : journal of the Moffitt Cancer Center.

[38]  A. Dejean,et al.  The role of Eomes in human CD4 T cell differentiation: A question of context , 2018, European journal of immunology.

[39]  K. Saliminejad,et al.  An overview of microRNAs: Biology, functions, therapeutics, and analysis methods , 2018, Journal of cellular physiology.

[40]  Tianfu Wu,et al.  Insulin-Like Growth Factor Binding Proteins in Autoimmune Diseases , 2018, Front. Endocrinol..

[41]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[42]  M. Barbouche,et al.  Impaired TGF‐&bgr; signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL‐22 , 2018, Cytokine.

[43]  K. Gillespie,et al.  Unravelling the Roles of Susceptibility Loci for Autoimmune Diseases in the Post-GWAS Era , 2018, Genes.

[44]  S. Tenzer,et al.  Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity , 2018, The EMBO journal.

[45]  Xiao Li,et al.  B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus , 2018, Front. Immunol..

[46]  Y. Tao,et al.  Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer , 2018, Molecular Cancer.

[47]  J. Nossent,et al.  Insulin-like growth factor-1 (IGF1) in systemic lupus erythematosus: relation to disease activity, organ damage and immunological findings , 2018, Lupus.

[48]  M. Østergaard,et al.  Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial , 2018, The Journal of Rheumatology.

[49]  M. Fawzy,et al.  MicroRNA–target cross-talks: Key players in glioblastoma multiforme , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[50]  Afaf T. Ibrahiem,et al.  MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma , 2017, Oxidative medicine and cellular longevity.

[51]  M. Fawzy,et al.  Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma , 2017, Respiratory Research.

[52]  N. Shen,et al.  Novel insights of microRNAs in the development of systemic lupus erythematosus , 2017, Current opinion in rheumatology.

[53]  Q. Lu,et al.  Translating epigenetics into clinic: focus on lupus , 2017, Clinical Epigenetics.

[54]  O. Peralta-Zaragoza,et al.  Functional polymorphisms in pre-miR146a and pre-miR499 are associated with systemic lupus erythematosus but not with rheumatoid arthritis or Graves’ disease in Mexican patients , 2017, Oncotarget.

[55]  I. Prinz,et al.  Eomes expression reports the progressive differentiation of IFN‐γ‐producing Th1‐like γδ T cells , 2017, European journal of immunology.

[56]  S. Salah,et al.  Unraveling the expression of microRNA‐27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients , 2017, International journal of rheumatic diseases.

[57]  X. Ke,et al.  A functional variant of miRNA‐149 confers risk for allergic rhinitis and comorbid asthma in Chinese children , 2017, International journal of immunogenetics.

[58]  G. Cheng,et al.  Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus , 2017, Arthritis Research & Therapy.

[59]  Ji-min Zhu,et al.  Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population , 2017, Rheumatology International.

[60]  L. Rönnblom,et al.  Systemic lupus erythematosus: still a challenge for physicians , 2017, Journal of internal medicine.

[61]  H. Lorenzi,et al.  High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus , 2016, PloS one.

[62]  C. Cogoni,et al.  MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions , 2016, International journal of molecular sciences.

[63]  M. Fawzy,et al.  MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors , 2016, Molecular Diagnosis & Therapy.

[64]  J. Ji,et al.  Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis , 2016, Autoimmunity.

[65]  M. Fawzy,et al.  Association of MicroRNA-196a2 Variant with Response to Short-Acting β2-Agonist in COPD: An Egyptian Pilot Study , 2016, PloS one.

[66]  M. Fawzy,et al.  Precursor miR-499a Variant but not miR-196a2 is Associated with Rheumatoid Arthritis Susceptibility in an Egyptian Population , 2016, Molecular Diagnosis & Therapy.

[67]  Jingpu Shi,et al.  Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility. , 2016, Human immunology.

[68]  J. Del Favero,et al.  Genetic variants in microRNA genes: impact on microRNA expression, function, and disease , 2015, Front. Genet..

[69]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[70]  Honglin Hu,et al.  rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression. , 2015, Biochemical and biophysical research communications.

[71]  V. Baekelandt,et al.  Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis , 2015, Brain, Behavior, and Immunity.

[72]  Chun-Shu Wong The Role of Adenomatous Polyposis Coli in T cell biology: Development, Naïve T cell maintenance, and T cell Homeostatic Proliferation. , 2015 .

[73]  Ge Yan,et al.  rs11671784 G/A and rs895819 A/G Polymorphisms Inversely Affect Gastric Cancer Susceptibility and miR-27a Expression in a Chinese Population , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[74]  Chang Liu,et al.  An Exploration of Evolution, Maturation, Expression and Function Relationships in Mir-23∼27∼24 Cluster , 2014, PloS one.

[75]  Yiguo Jiang,et al.  Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility , 2014, Oncogene.

[76]  Yong Zhu,et al.  A regulatory circuit comprising GATA1/2 switch and microRNA-27a/24 promotes erythropoiesis , 2013, Nucleic acids research.

[77]  Li He,et al.  MicroRNA-499 rs3746444 Polymorphism and Autoimmune Diseases Risk: A Meta-Analysis , 2014, Molecular Diagnosis & Therapy.

[78]  A. El-Shal,et al.  Association of microRNAs genes polymorphisms with rheumatoid arthritis in Egyptian female patients. , 2013, Joint, bone, spine : revue du rhumatisme.

[79]  K. Nakayama,et al.  F-box and WD Repeat Domain-containing-7 (Fbxw7) Protein Targets Endoplasmic Reticulum-anchored Osteogenic and Chondrogenic Transcriptional Factors for Degradation* , 2013, The Journal of Biological Chemistry.

[80]  Lin Wang,et al.  Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis , 2013, PloS one.

[81]  A. La Cava,et al.  miRNA in systemic lupus erythematosus. , 2012, Clinical immunology.

[82]  A. Pozzi,et al.  The role of cell-extracellular matrix interactions in glomerular injury. , 2012, Experimental cell research.

[83]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[84]  C. Vrabie,et al.  Manifestations of systemic lupus erythematosus. , 2011, Maedica.

[85]  T. Ha The Role of MicroRNAs in Regulatory T Cells and in the Immune Response , 2011, Immune network.

[86]  J. Rice,et al.  Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function , 2010, Proceedings of the National Academy of Sciences.

[87]  N. Saini,et al.  Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases , 2010, Molecular Cancer.

[88]  J. Pelletier,et al.  Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes , 2009, BMC musculoskeletal disorders.

[89]  John J Rossi,et al.  SNPs in human miRNA genes affect biogenesis and function. , 2009, RNA.

[90]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[91]  D. Leake,et al.  Functional Profiling Reveals Critical Role for miRNA in Differentiation of Human Mesenchymal Stem Cells , 2009, PloS one.

[92]  Kaleb M. Pauley,et al.  MicroRNA in autoimmunity and autoimmune diseases. , 2009, Journal of autoimmunity.

[93]  Jianping Ye,et al.  A role of miR‐27 in the regulation of adipogenesis , 2009, The FEBS journal.

[94]  Klaus Rajewsky,et al.  MicroRNA Control in the Immune System: Basic Principles , 2009, Cell.

[95]  J. Lotem,et al.  A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis , 2009, Proceedings of the National Academy of Sciences.

[96]  J. D. de Sanctis,et al.  Decreased transcription, expression and function of low-density lipoprotein receptor in leukocytes from patients with systemic lupus erythematosus , 2009, Autoimmunity.

[97]  A. Nanda Autoimmune Diseases Associated with Neurofibromatosis Type 1 , 2008, Pediatric dermatology.

[98]  Shih-Chang Lin,et al.  Altered FOXO1 Transcript Levels in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients , 2007, Molecular medicine.

[99]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[100]  R. Pawankar,et al.  The role of matrix metalloproteinase (MMP)-2, MMP-9, and MMP-13 in bullous pemphigoid , 2004 .

[101]  V. Rotter,et al.  Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies. , 2001, Journal of autoimmunity.

[102]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[103]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[104]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .